Russian drug effective against both Delta & Omicron

分享在 facebook
分享在 linkedin
分享在 twitter
分享在 email
RAEL’S COMMENT: 
And the law is very clear: if there is a medicine against a disease, a vaccine cannot be administered.

Avifavir targets the core of coronavirus, which doesn’t change from strain to strain

The team of Russian scientists behind a new Covid-19 drug, Avifavir, have issued a statement in which they insist that it is highly effective against the two strains of coronavirus, Delta and Omicron, that are currently dominant.

Covid-19, like most other ribonucleic acids (RNA) viruses, is known to be highly prone to mutation, but the formula’s developers say it remains effective regardless of the strain, as it targets the highly stable part of the virus.

Based on the antiviral medication favipiravir, the Russian drug targets the “genetically highly conservative RNA virus replication systems” that do not undergo mutation from strain to strain, according to a statement released on Monday by the manufacturer, ChemRar Group. The researchers report that the virus is unable to develop resistance to the drug “even with prolonged exposure of virus-infected cells to the product.”

Read more

Source

瞭解真相

閱讀1973年雷爾接觸UFO期間我們的創造者給我們的訊息!

其他活動

關注我們

雷爾學院

you might also like